Cart
sales@molnova.com
δ-Valerolactone
CAS No. 542-28-9
δ-Valerolactone( Tetrahydro-2H-pyran-2-one | δ-Valeryllactone | 2-Oxotetrahydropyran )
Catalog No. M19622 CAS No. 542-28-9
δ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameδ-Valerolactone
-
NoteResearch use only, not for human use.
-
Brief Descriptionδ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
-
Descriptionδ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
-
In Vitro——
-
In Vivo——
-
SynonymsTetrahydro-2H-pyran-2-one | δ-Valeryllactone | 2-Oxotetrahydropyran
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number542-28-9
-
Formula Weight100.12
-
Molecular FormulaC5H8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C1CCCCO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Houk K. Jabbari A. Hall H. & Alemán C. (2008). Why δ-Valerolactone Polymerizes and γ-Butyrolactone Does Not. The Journal Of Organic Chemistry 73(7) 2674-2678. doi: 10.1021/jo702567v
molnova catalog
related products
-
Leucoside
Leucoside is a naturally occuring flavonol bioside with many biological activities.
-
Naratriptan hydrochl...
Naratriptan Hydrochloride is the hydrochloride salt form of naratriptan, a sulfonamide with selective serotonin (5-HT) 1 receptor agonistic activity and anti-migraine property.
-
PF-00835231
PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively.PF-00835231 is the active compound of the first anti-3CLpro regimen in clinical trials.
